INSPIRE MEDICAL SYSTEMS INC

INSPNYSE

🏆 #1985 by market capEarnings Nov 2 · PostUS Equity

$902.16▲ $41.95 (+4.65%)

Simulated price

🔔

Track INSP

Get earnings, price moves & breaking news on Telegram

Track

24h▲ 4.7%

7d—

14d—

30d—

ytd—

1y—

🏦Market Cap

$2.02B

Small Cap

📈Revenue Growth (YoY)

+13.6%

Healthy

📊Gross Margin

86.1%

High

💵FCF Margin

13.0%

Healthy

⚖️P/S Ratio

2.3x

Cheap

Otter Score

Fair

INSPIRE MEDICAL SYSTEMS INC

INSP

Analyst Ratings

Price

$902.16

Total

Raised

Lowered

Avg PT

$60.80

H / L

$85 / $39

Institution	Action	Rating	Date		Upside
Freedom Capital Markets	Reiterated	Buy	2026-09-21	—	—
Stifel	Reiterated	Buy	2026-09-11	—	—
Baird	Reiterated	Neutral	2026-08-04	—	—
Mizuho	Reiterated	Outperform	2026-08-04	—	—
Oppenheimer	Upgraded	Perform → Outperform	2026-08-04	$85.00	−90.60%
JP Morgan	Reiterated	Neutral	2026-08-04	$300.00	−66.70%
Truist Securities	Reiterated	Hold	2026-08-04	—	—
Evercore ISI Group	Reiterated	In Line	2026-08-04	—	—
Piper Sandler	Reiterated	Neutral	2026-08-04	$60.00	−93.30%
Wells Fargo	Reiterated	Equal Weight	2026-05-05	$70.00	−92.20%
RBC Capital	Reiterated	Sector Perform	2026-05-05	$60.00	−93.30%
Wolfe Research	Downgraded	Outperform → Peer Perform	2026-02-13	$180.00	−80.00%
Jefferies	Reiterated	Hold	2026-02-12	$230.00	−74.50%
UBS	Reiterated	Neutral	2025-12-23	$39.00	−95.70%
Morgan Stanley	Downgraded	Overweight → Equal Weight	2025-12-02	$60.00	−93.30%
Leerink Partners	Reiterated	Market Perform	2025-08-15	—	—
Keybanc	Downgraded	Overweight → Sector Weight	2025-08-05	—	—
Lake Street	Reiterated	Buy	2025-08-05	$150.00	−83.40%
B of A Securities	Upgraded	Neutral → Buy	2024-11-20	—	—
Goldman Sachs	Upgraded	Neutral → Buy	2022-12-13	—	—
SVB Leerink	Reiterated	Outperform	2022-02-09	—	—
Guggenheim	Reiterated	Buy	2020-05-06	—	—
Berenberg	Upgraded	Sell → Hold	2019-11-06	—	—
Leerink Swann	Reiterated	Outperform	2018-10-29	—	—
Stifel Nicolaus	Reiterated	Buy	2018-05-29	$80.00	−91.10%
Albert Fried	Reiterated	Market Perform	2012-05-11	—	—
Albert Fried & Co.	Reiterated	Market Perform	2012-05-10	—	—
Benchmark	Reiterated	Buy	2012-04-23	—	—

Institution

Freedom Capital Markets

Reiterated · Buy · 2026-09-21

—

Stifel

Reiterated · Buy · 2026-09-11

—

Baird

Reiterated · Neutral · 2026-08-04

—

Mizuho

Reiterated · Outperform · 2026-08-04

—

Oppenheimer

Upgraded · Perform → Outperform · 2026-08-04

$85.00

−90.60%

JP Morgan

Reiterated · Neutral · 2026-08-04

$300.00

−66.70%

Truist Securities

Reiterated · Hold · 2026-08-04

—

Evercore ISI Group

Reiterated · In Line · 2026-08-04

—

Piper Sandler

Reiterated · Neutral · 2026-08-04

$60.00

−93.30%

Wells Fargo

Reiterated · Equal Weight · 2026-05-05

$70.00

−92.20%

RBC Capital

Reiterated · Sector Perform · 2026-05-05

$60.00

−93.30%

Wolfe Research

Downgraded · Outperform → Peer Perform · 2026-02-13

$180.00

−80.00%

Jefferies

Reiterated · Hold · 2026-02-12

$230.00

−74.50%

UBS

Reiterated · Neutral · 2025-12-23

$39.00

−95.70%

Morgan Stanley

Downgraded · Overweight → Equal Weight · 2025-12-02

$60.00

−93.30%

Leerink Partners

Reiterated · Market Perform · 2025-08-15

—

Keybanc

Downgraded · Overweight → Sector Weight · 2025-08-05

—

Lake Street

Reiterated · Buy · 2025-08-05

$150.00

−83.40%

B of A Securities

Upgraded · Neutral → Buy · 2024-11-20

—

Goldman Sachs

Upgraded · Neutral → Buy · 2022-12-13

—

SVB Leerink

Reiterated · Outperform · 2022-02-09

—

Guggenheim

Reiterated · Buy · 2020-05-06

—

Berenberg

Upgraded · Sell → Hold · 2019-11-06

—

Leerink Swann

Reiterated · Outperform · 2018-10-29

—

Stifel Nicolaus

Reiterated · Buy · 2018-05-29

$80.00

−91.10%

Albert Fried

Reiterated · Market Perform · 2012-05-11

—

Albert Fried & Co.

Reiterated · Market Perform · 2012-05-10

—

Benchmark

Reiterated · Buy · 2012-04-23

—

One row per institution · price target from the firm's latest published target

StockOtter · stockotter.space